This research establishes the direct link between 'Patent Quality' and 'Exit Route'. It demonstrates that startups with high-quality, radical innovation (measured by patent citations) are statistically more likely to IPO, whereas incremental innovations tend to result in trade sales (M&A). The paper argues that the IPO market acts as a filter for 'systemic' innovation, while M&A serves as a mechanism for incumbents to acquire 'bolt-on' features. It also analyzes how 'Grandstanding' (VCs taking companies public early to raise new funds) distorts this dynamic.

Not all exits are created equal. For DeepTech founders, this validates the strategy of building a defensible IP moat as the primary path to a public listing. It warns against 'premature scaling' without foundational IP, which often forces a discounted M&A exit. It is a guide to engineering your startup's DNA for the public markets from day one.